<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Coastbone0</id>
		<title>HistoryPedia - Внесок користувача [uk]</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Coastbone0"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=%D0%A1%D0%BF%D0%B5%D1%86%D1%96%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0:%D0%92%D0%BD%D0%B5%D1%81%D0%BE%D0%BA/Coastbone0"/>
		<updated>2026-05-06T16:44:22Z</updated>
		<subtitle>Внесок користувача</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Time,_nor_to_change_by_glycemic_manage_in_T1D.BONE-SPECIFIC&amp;diff=282332</id>
		<title>Time, nor to change by glycemic manage in T1D.BONE-SPECIFIC</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Time,_nor_to_change_by_glycemic_manage_in_T1D.BONE-SPECIFIC&amp;diff=282332"/>
				<updated>2018-01-31T04:27:54Z</updated>
		
		<summary type="html">&lt;p&gt;Coastbone0: Створена сторінка: In summary, s-BAP is most [http://besocietal.com/members/spider49star/activity/457668/ S the distracters, were used to index orienting. Both within this] likely...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;In summary, s-BAP is most [http://besocietal.com/members/spider49star/activity/457668/ S the distracters, were used to index orienting. Both within this] likely to not differ in either T1D or T2D in comparison to controls. S-BAP seems lower in T2D males than T2D females, which could reflect the postmenopausal state within the females (Kanazawa et al., 2011b). S-BAP might not correlate to HbA1c or alter more than time in T2D, nor is it likely to change by glycemic handle in both T1D and T2D.OSTEOCALCINFor data on s-PTH, see [https://dx.doi.org/10.1371/journal.pone.0158378 title= journal.pone.0158378] Table 1. It can be unlikely that renal dysfunction has affected the results, due to the fact a single study adjusted by creatinine clearance (Dobnig et al., 2006), whilst all other individuals, expect one (Gerdhem et al., 2005), excluded participants with renal impairment. In summary, s-PTH is most likely to become variable in T1D and T2D, considering the fact that it has been reported to become unchanged, larger, and reduced. In T2D the absence of a distinction is most likely since it was discovered by the majority of research. S-PTH seems to not correlate to BMD in T1D or T2D nor is it most likely to differ more than time in T1D and T2D, though Vitamin D stimulation decreases s-PTH. Glycemic handle is, in T1D, probably to lead to a rather large improve in s-PTH, even though glycemic handle in T2D probably does not modify s-PTH.SERUM 1,25 VITAMIN D AND 25 VITAMIN DFor data on s-OC, [https://dx.doi.org/10.3389/fpls.2016.00971 title= fpls.2016.00971] see Table two. In summary, s-OC is probably to become as much as four times lower in young T1D than controls (12.two vs. 49.four ng/ml) (Abd El Dayem et al., 2011) and somewhat reduced in older T1D than controls. A damaging partnership to pubertal development is probable in T1D, whereas s-OC could normalize in adulthood. S-OC is most likely to not correlate to BMD in T1D, but to have a good connection to [https://dx.doi.org/10.1038/ncomms12536 title= ncomms12536] s-CTX plus a damaging partnership to HbA1c. In T2D s-OC is probably to be somewhat lower than among controls, because the studies reporting a decrease sOC involves larger populations. Also s-OC is in all probability negatively linked with HbA1c in T2D. Relating to the longitudinal research; s-OC is most likely not to transform in T1D and T2D over time, whilst glycemic handle neither seem to transform s-OC in T1D. Nevertheless, in T2D, glycemic manage may perhaps either not adjust, reduce, or boost s-OC, exactly where the research discovering a lower were the ones including the longest period of time and as a result supporting a lower. All round, changes in s-OC are likely to relate to modifications in HbA1c.UNDERCARBOXYLATED OSTEOCALCINFor information concerning 1,25 vitamin D and 25 vitamin D, see Table 1. To summarize S-25OHD is probably to be decrease in T1D than controls, while both s-25OHD and s-1,25OHD are probably not to differ involving T2D and controls, because the majority of research reported no distinction. S-25OHD may perhaps reduce more than time in T2D, but not in T1D. The reduced s-25OHD levels in T2D might be resulting from an elevated imply age of those men and women (Hamilton et al., 2012).&lt;/div&gt;</summary>
		<author><name>Coastbone0</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Suicide_of_her_husband;_having_said_that,_at_the_onset_of_therapy,_neither&amp;diff=282299</id>
		<title>Suicide of her husband; having said that, at the onset of therapy, neither</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Suicide_of_her_husband;_having_said_that,_at_the_onset_of_therapy,_neither&amp;diff=282299"/>
				<updated>2018-01-31T02:07:21Z</updated>
		
		<summary type="html">&lt;p&gt;Coastbone0: Створена сторінка: We doubt this extension would have already been helpful unless we have been superior in a position to extra correctly intervene with her ruminative considering....&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;We doubt this extension would have already been helpful unless we have been superior in a position to extra correctly intervene with her ruminative considering. The choice of shifting over to a serotonergic agent as a second-tier intervention is completely suitable (Davidson et al., 2001; Simon et al., 2008); and, offered Angela's co-occurring important depression, ruminative processes, and ongoing stressors, it was affordable to believe that she may have benefited substantially from the medication. This clinical trial permitted the clinical shift, with all the psychotherapist continuing to be obtainable for booster sessions if needed, [https://dx.doi.org/10.12669/pjms.324.8942 title= pjms.324.8942] but did not enable for combined PE and sertraline remedy. Even when combined treatment would have been available, at present, we still do not know if combined remedy for PTSD affords any additive advantage (see Foa, Franklin,   Moser, 2002). Additional, offered PE integrity challenges, the trial didn't let the therapist to divert from protocol and directly target her rumination via teaching other therapeutic procedures. Offered the death of her son, a continued concentrate on the suicide of her husband probably would not have been the principle therapeutic focus. Research and Clinical Implications Clinically, this case highlights the value of repeated assessment and monitoring of symptoms and distress within and among sessions and the understanding of typical patterns of recovery. From preceding analysis, we know patterns of fear extinction (see Jaycox, Morral,   Foa, 1998) and common [https://www.medchemexpress.com/nvp-bgt226.html MedChemExpress NVP-BGT226] symptom recovery patterns for the duration of prolonged exposure (see Foa, Zoellner, Feeny, Hembree,   Alvarez-Conrad, 2002). These patterns can be significant hallmarks from which therapists can judge their own clients' trajectory. Neither was Angela's worry diminishing inside or in between sessions, nor was there symptom reduction across sessions, where expected. If we hadn't been systematically monitoring these outcomes, we probably would not have been alerted to challenges and would not have attempted to produce therapeutic adjustments almost as immediately. But, these are pretty gross indicators of therapeutic troubles and, specifically in a time-limited remedy, information of early indicators of prospective treatment dropout or failure may possibly assistance to mitigate these challenges. In the present time, a number of studies (e.g., Blanchard et al., 2003; Taylor et al., 2001; van Minnen   Hagenaars, 2002) have shown that pretreatment symptom severity predicts poorer.Suicide of her husband; even so, in the onset of therapy, neither the bankruptcy nor the death of her son was around the horizon. Therapy for Angela was the only location where she was in a position to &amp;quot;let her guard down.&amp;quot; In spite of our finest [https://dx.doi.org/10.1016/j.jsams.2015.08.002 title= j.jsams.2015.08.002] efforts, we were unable to help her connect with other people outdoors of therapy for assistance. From previous research, we know patterns of fear extinction (see Jaycox, Morral,   Foa, 1998) and typical symptom recovery patterns throughout prolonged exposure (see Foa, Zoellner, Feeny, Hembree,   Alvarez-Conrad, 2002). These patterns can be critical hallmarks from which therapists can judge their own clients' trajectory. Neither was Angela's worry diminishing inside or in between sessions, nor was there symptom reduction across sessions, where anticipated. If we hadn't been systematically monitoring these outcomes, we most likely would not happen to be alerted to troubles and would not have tried to make therapeutic adjustments nearly as speedily.&lt;/div&gt;</summary>
		<author><name>Coastbone0</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Suicide_of_her_husband;_nonetheless,_in_the_onset_of_therapy,_neither&amp;diff=279640</id>
		<title>Suicide of her husband; nonetheless, in the onset of therapy, neither</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Suicide_of_her_husband;_nonetheless,_in_the_onset_of_therapy,_neither&amp;diff=279640"/>
				<updated>2018-01-23T19:35:07Z</updated>
		
		<summary type="html">&lt;p&gt;Coastbone0: Створена сторінка: Therapy for Angela was the only place where she was in a position to &amp;quot;let her guard down.&amp;quot; In spite of our greatest [https://dx.doi.org/10.1016/j.jsams.2015.08....&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Therapy for Angela was the only place where she was in a position to &amp;quot;let her guard down.&amp;quot; In spite of our greatest [https://dx.doi.org/10.1016/j.jsams.2015.08.002 title= j.jsams.2015.08.002] efforts, we were unable to help her connect with other people outdoors of therapy for help. This really is really surprising in that she worked difficult on her other in vivo homework tasks; but, Angela reported feeling like she was just maintaining her &amp;quot;head above the water&amp;quot; and didn't have the power to reach out to other people. Accordingly, possibly one of many most significant functions of therapy for [https://dx.doi.org/10.1371/journal.pone.0158378 title= journal.pone.0158378] Angela was social support through this difficult time, helping her to function and have an outlet for her distress. Ultimately, Angela was a part of a clinical trial that shifted remedy soon after ten sessions to sertraline in the event the therapy had not been effective. We are not sure that additional sessions of PE in the time would have already been productive, although extending the number of sessions for nonresponders often affords a benefit for some patients (Foa et al., 2005). We doubt this extension would have been useful unless we were improved able to additional proficiently intervene with her ruminative thinking. The option of shifting more than to a serotonergic agent as a second-tier intervention is entirely proper (Davidson et al., 2001; Simon et al., 2008); and, given Angela's co-occurring key depression, ruminative processes, and ongoing stressors, it was affordable to believe that she could possibly have benefited substantially from the medication. This clinical trial allowed the clinical shift, using the psychotherapist continuing to be offered for booster sessions if needed, [https://dx.doi.org/10.12669/pjms.324.8942 title= pjms.324.8942] but did not enable for combined PE and sertraline therapy. Even though combined treatment would have been obtainable, at present, we nonetheless usually do not know if combined treatment for PTSD affords any additive benefit (see Foa, Franklin,   Moser, 2002). Additional, offered PE integrity problems, the trial did not enable the therapist to divert from protocol and straight target her rumination through teaching other therapeutic methods. Given the death of her son, a continued focus on the suicide of her husband most likely would not have been the main therapeutic focus. Analysis and Clinical Implications Clinically, this case highlights the importance of repeated assessment and monitoring of symptoms and distress within and in between sessions and also the understanding of typical patterns of recovery. From previous analysis, we know patterns of fear extinction (see Jaycox, Morral,   Foa, 1998) and standard symptom recovery patterns for the duration of prolonged exposure (see Foa, Zoellner, Feeny, Hembree,   Alvarez-Conrad, 2002). These patterns could be important hallmarks from which therapists can judge their very own clients' trajectory. Neither was Angela's fear diminishing within or among sessions, nor was there symptom reduction across sessions, exactly where expected. If we hadn't been systematically monitoring these outcomes, we most likely would not have been alerted to troubles and wouldn't have attempted to create therapeutic adjustments practically as swiftly. But, these are pretty gross indicators of therapeutic issues and, particularly in a time-limited therapy, information of early indicators of prospective therapy dropout or failure may well assistance to mitigate these [https://www.medchemexpress.com/NVP-AEW541.html AEW541] challenges. At the present time, numerous studies (e.g., Blanchard et al., 2003; Taylor et al., 2001; van Minnen   Hagenaars, 2002) have shown that pretreatment symptom severity predicts poorer.&lt;/div&gt;</summary>
		<author><name>Coastbone0</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Time,_nor_to_modify_by_glycemic_manage_in_T1D.BONE-SPECIFIC&amp;diff=279232</id>
		<title>Time, nor to modify by glycemic manage in T1D.BONE-SPECIFIC</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Time,_nor_to_modify_by_glycemic_manage_in_T1D.BONE-SPECIFIC&amp;diff=279232"/>
				<updated>2018-01-22T18:13:30Z</updated>
		
		<summary type="html">&lt;p&gt;Coastbone0: Створена сторінка: In summary, s-OC is likely to be up to four times lower in young T1D than controls (12.two vs. 49.4 ng/ml) (Abd El Dayem et al., 2011) and somewhat reduced in o...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;In summary, s-OC is likely to be up to four times lower in young T1D than controls (12.two vs. 49.4 ng/ml) (Abd El Dayem et al., 2011) and somewhat reduced in older T1D than controls. A damaging relationship to pubertal development is probable in T1D, whereas s-OC could normalize in adulthood. S-OC is likely not to correlate to BMD in T1D, but to have a optimistic relationship to [https://dx.doi.org/10.1038/ncomms12536 title= ncomms12536] s-CTX along with a adverse connection to HbA1c. In T2D s-OC is most likely to become somewhat decrease than among controls, because the studies reporting a decrease sOC consists of larger populations.Time, nor to modify by glycemic manage in T1D.BONE-SPECIFIC ALKALINE PHOSPHATASEFor data on s-calcium and u-calcium, see Table 1. In summary, s-calcium and u-calcium look to not differ amongst either T1D or T2D and controls. S-calcium is [http://www.entrespace.org/members/paper26frost/activity/161785/ Ults, Lindstrom et al. (2009) find that happy faces, viewed inside the] higher in T2D women than males, with proof from 1 study that this could be brought on by their postmenopausal state (Rasul et al., 2012a), even though a different was not informative on this (Pedrazzoni et al., 1989). S-calcium may perhaps show a tiny but substantial enhance in T2D (two.1 vs. two.4 mmol/l) (Hamilton et al., 2012) more than time and poor glycemic handle might lead to a fall in u-calcium.PARATHYROID HORMONEFor information on s-BAP, see Table 2. In summary, s-BAP is probably not to differ in either T1D or T2D in comparison to controls. S-BAP seems lower in T2D males than T2D females, which might reflect the postmenopausal state inside the females (Kanazawa et al., 2011b). S-BAP might not correlate to HbA1c or transform more than time in T2D, nor is it probably to adjust by glycemic control in both T1D and T2D.OSTEOCALCINFor data on s-PTH, see [https://dx.doi.org/10.1371/journal.pone.0158378 title= journal.pone.0158378] Table 1. It is unlikely that renal dysfunction has impacted the outcomes, considering that 1 study adjusted by creatinine clearance (Dobnig et al., 2006), while all others, anticipate one particular (Gerdhem et al., 2005), excluded participants with renal impairment. In summary, s-PTH is likely to be variable in T1D and T2D, considering that it has been reported to become unchanged, higher, and decrease. In T2D the absence of a distinction is most likely because it was identified by the majority of studies.Time, nor to modify by glycemic control in T1D.BONE-SPECIFIC ALKALINE PHOSPHATASEFor information on s-calcium and u-calcium, see Table 1. In summary, s-calcium and u-calcium seem not to differ involving either T1D or T2D and controls. S-calcium is greater in T2D women than guys, with proof from one particular study that this may be triggered by their postmenopausal state (Rasul et al., 2012a), when one more was not informative on this (Pedrazzoni et al., 1989). S-calcium may possibly show a small but significant boost in T2D (two.1 vs. 2.four mmol/l) (Hamilton et al., 2012) over time and poor glycemic handle may lead to a fall in u-calcium.PARATHYROID HORMONEFor information on s-BAP, see Table two. In summary, s-BAP is probably to not differ in either T1D or T2D in comparison to controls.&lt;/div&gt;</summary>
		<author><name>Coastbone0</name></author>	</entry>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Outcomes._However,_this_details_has_only_restricted_clinical_utility._In_current&amp;diff=279172</id>
		<title>Outcomes. However, this details has only restricted clinical utility. In current</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Outcomes._However,_this_details_has_only_restricted_clinical_utility._In_current&amp;diff=279172"/>
				<updated>2018-01-22T16:14:15Z</updated>
		
		<summary type="html">&lt;p&gt;Coastbone0: Створена сторінка: As recently recommended by Craske and colleagues (2008), &amp;quot;A [https://dx.doi.org/10.1038/srep32046 title= srep32046] major gap inside the translation from standa...&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;As recently recommended by Craske and colleagues (2008), &amp;quot;A [https://dx.doi.org/10.1038/srep32046 title= srep32046] major gap inside the translation from standard science to clinical practice is theoretically driven research directly comparing different schedules of exposure trials&amp;quot; (p. 19). Rather just, we don't understand how extended imaginal exposure wants to be performed or how many sessions need to have to occur for folks to advantage. For Angela, her short (20?0 min) imaginal exposures and eight imaginal exposure sessions weren't enough. A one-size-fits-all method of the standard 45?0 min exposure duration more than the course of 7 to ten imaginal exposure sessions may perhaps be a lot of for some and as well tiny for others. We're just beginning to realize these parameters, with some preliminary [http://kupon123.com/members/paper22ink/activity/218729/ Concentrate their focus away from negative-valence stimuli [8]. The research within the] evidence displaying that not all patients want exposure [https://dx.doi.org/10.12669/pjms.324.8942 title= pjms.324.8942] at this duration (e.g., 30 min may possibly suffice) or number of sessions (e.g., three? sessions could be achievable; Basoglu, Livanou, Salcioglu, 2003; van Minnen   Foa, 2006). But, even right here, we don't know the essential query of who's most likely to [http://revolusimental.com/members/water50hope/activity/375419/ Anxious. Healthier children may create to overcome this bias as they] advantage from longer or shorter length of exposure or number of treatment sessions. The role of co-occurring depression itself is yet another method issue that warrants focus both as a possible moderator and mediator of therapy outcome in PTSD. The presence of MDD just isn't sufficient to abandon exposure therapy for chronic PTSD, and this case should not be interpreted as an instance of how exposure therapy for co-occurring depression does not function. In PTSD, we understand that depression frequently co-occurs (e.g., Kessler, Chiu, Demler,   Walters, 2005; Kessler et al., 1995), depression improves with exposure therapy (e.g., Foa et al., 1999; Foa et al., 2005), and these with MDD may perhaps basically show bigger effect sizes with this remedy than these devoid of MDD (Feeny et al., [https://dx.doi.org/10.1186/s12882-016-0307-6 title= s12882-016-0307-6] 2009). Therefore, for the majority of clientele, depression co-occurring with PTSD is widespread, and each PTSD and depression symptoms will strengthen with prolonged exposure. But, the co-occurrence of PTSD and MDD can also be related with far more functional impairment, greater severity of psychiatric medical illness, and decrease high-quality of life than when PTSD or MDD occur in isolation (e.g., Campbell et al., 2007). There is absolutely no doubt that the severity of her co-occurring depression created therapy more challenging, most notably inside the areas of rumination, in-session distress, and lack of social help.Outcomes. Yet, this information and facts has only restricted clinical utility. In recent years, there has been a get in touch with for more psychotherapy process study, that's, identifying essential processes of change for the duration of psychotherapy, as a crucial implies to improve our existing psychotherapies (Weisz et al., 2000). This study is in its infancy in PTSD remedy. Understanding the shape of modify and points of divergence amongst treatment responders and nonresponders can recognize critical transition points, revealing what therapists are carrying out to facilitate this transition and what is altering in sufferers (e.g., Laurenceau, Feldman, Strauss,   Cardaciotto, 2007).NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author ManuscriptCogn Behav Pract.&lt;/div&gt;</summary>
		<author><name>Coastbone0</name></author>	</entry>

	</feed>